speb/financial-data huggingface dataset:
UMBFO cash_flow (quarterly, 2025-09-30) — Net Preferred Stock Issuance: -114996000.00
UMBFO cash_flow (quarterly, 2025-09-30) — Net Short Term Debt Issuance: 0.00
UMBFO balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 5097202000.00
UMBFO income_statement (quarterly, 2025-09-30) — Normalized Income: 188316000.00
UMBFO income_statement (quarterly, 2025-09-30) — Occupancy And Equipment: 35712000.00
UMBFO cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 272209000.00
UMBFO cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -7858000.00
UMBFO income_statement (quarterly, 2025-09-30) — Operating Revenue: 621557000.00
UMBFO balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 75953713.00
UMBFO balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -324842000.00
UMBFO balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 511450000.00
UMBFO cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 3612000.00
UMBFO income_statement (quarterly, 2025-09-30) — Other Non Interest Expense: 48434000.00
UMBFO balance_sheet (quarterly, 2025-09-30) — Other Receivables: 439064000.00
UMBFO balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 8406975000.00
UMBFO balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 453437000.00
UMBFO balance_sheet (quarterly, 2025-09-30) — Preferred Securities Outside Stock Equity: 218929000.00
UMBFO balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 294066000.00
UMBFO income_statement (quarterly, 2025-09-30) — Preferred Stock Dividends: 7944000.00
UMBFO balance_sheet (quarterly, 2025-09-30) — Preferred Stock Equity: 294066000.00
UMBFO cash_flow (quarterly, 2025-09-30) — Preferred Stock Issuance: 4000.00
UMBFO income_statement (quarterly, 2025-09-30) — Pretax Income: 236555000.00
UMBFO cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 272000.00
UMBFO income_statement (quarterly, 2025-09-30) — Professional Expense And Contract Services Expense: 21616000.00
UMBFO cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -1765773000.00
UMBFO cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -14398000.00
UMBFO balance_sheet (quarterly, 2025-09-30) — Receivables: 439064000.00
UMBFO income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 37012000.00
UMBFO cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -188945000.00
UMBFO cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -116301000.00
UMBFO balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 3559717000.00
UMBFO income_statement (quarterly, 2025-09-30) — Salaries And Wages: 220329000.00
UMBFO cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 555362000.00
UMBFO income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 11094000.00
UMBFO income_statement (quarterly, 2025-09-30) — Selling General And Administration: 231423000.00
UMBFO balance_sheet (quarterly, 2025-09-30) — Share Issued: 78665809.00
UMBFO cash_flow (quarterly, 2025-09-30) — Short Term Debt Issuance: 0.00
UMBFO cash_flow (quarterly, 2025-09-30) — Short Term Debt Payments: 0.00
UMBFO cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 7723000.00
UMBFO balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 7443950000.00
UMBFO balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 4803136000.00
UMBFO income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
UMBFO income_statement (quarterly, 2025-09-30) — Tax Provision: 48239000.00
UMBFO income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.20
UMBFO balance_sheet (quarterly, 2025-09-30) — Total Assets: 71881181000.00
UMBFO balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 7696352000.00
UMBFO balance_sheet (quarterly, 2025-09-30) — Total Debt: 252402000.00
UMBFO balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 7443950000.00
UMBFO balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 64437231000.00
UMBFO balance_sheet (quarterly, 2025-09-30) — Trading Securities: 35811000.00
UMBFO balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 2712096.00
UMBFO balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 165491000.00
UMBFO income_statement (annual, 2025-12-31) — +Total Revenue: 2429906000.00
UMBFO income_statement (quarterly, 2025-12-31) — +Total Revenue: 664949000.00
UMBFO balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -447049000.00
UMBFO balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -447049000.00
UMBFO balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 4011047000.00
UMBFO balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 4011047000.00
UMBFO income_statement (annual, 2025-12-31) — Amortization: 93521000.00
UMBFO income_statement (quarterly, 2025-12-31) — Amortization: 25454000.00
UMBFO income_statement (annual, 2025-12-31) — Amortization Of Intangibles Income Statement: 93521000.00
UMBFO income_statement (quarterly, 2025-12-31) — Amortization Of Intangibles Income Statement: 25454000.00
UMBFO balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 5470914000.00
UMBFO balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 5470914000.00
UMBFO cash_flow (annual, 2025-12-31) — Beginning Cash Position: 8448691000.00
UMBFO cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 8841410000.00
UMBFO balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 516006000.00
UMBFO balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 516006000.00
UMBFO cash_flow (annual, 2025-12-31) — Capital Expenditure: -48584000.00
UMBFO cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -10759000.00
UMBFO balance_sheet (annual, 2025-12-31) — Capital Stock: 372732000.00
UMBFO balance_sheet (quarterly, 2025-12-31) — Capital Stock: 372732000.00
UMBFO balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 7893082000.00
UMBFO balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 7893082000.00
UMBFO balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Federal Funds Sold: 9441175000.00
UMBFO balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Federal Funds Sold: 9441175000.00
UMBFO cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -135620000.00
UMBFO cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -40614000.00
UMBFO balance_sheet (annual, 2025-12-31) — Cash Financial: 952547000.00
UMBFO balance_sheet (quarterly, 2025-12-31) — Cash Financial: 952547000.00
UMBFO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 3916687000.00
UMBFO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 966961000.00
UMBFO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -5620098000.00
UMBFO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -2142475000.00
UMBFO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 1026693000.00
UMBFO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 106077000.00
UMBFO cash_flow (annual, 2025-12-31) — Change In Accrued Expense: 26247000.00
UMBFO cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: -16086000.00
UMBFO cash_flow (annual, 2025-12-31) — Change In Other Working Capital: 83176000.00
UMBFO cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: -163413000.00
UMBFO cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 26247000.00
UMBFO cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -16086000.00
UMBFO cash_flow (annual, 2025-12-31) — Change In Receivables: -29265000.00
UMBFO cash_flow (quarterly, 2025-12-31) — Change In Receivables: -17994000.00
UMBFO cash_flow (annual, 2025-12-31) — Change In Working Capital: 80158000.00
UMBFO cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -197493000.00
UMBFO cash_flow (annual, 2025-12-31) — Changes In Cash: -676718000.00
UMBFO cash_flow (quarterly, 2025-12-31) — Changes In Cash: -1069437000.00
UMBFO balance_sheet (annual, 2025-12-31) — Common Stock: 78666000.00
UMBFO balance_sheet (quarterly, 2025-12-31) — Common Stock: 78666000.00
UMBFO cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -135620000.00
UMBFO cash_flow (quarterly, 2025-12-31) — Common Stock Dividend Paid: -40614000.00
UMBFO balance_sheet (annual, 2025-12-31) — Common Stock Equity: 7399502000.00
UMBFO balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 7399502000.00
UMBFO cash_flow (annual, 2025-12-31) — Common Stock Issuance: 235141000.00
UMBFO cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 0.00
UMBFO cash_flow (annual, 2025-12-31) — Common Stock Payments: -17628000.00
UMBFO cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -79000.00
UMBFO balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 435351000.00
UMBFO balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 435351000.00
UMBFO cash_flow (annual, 2025-12-31) — Deferred Income Tax: 82825000.00
UMBFO cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: 57606000.00
UMBFO cash_flow (annual, 2025-12-31) — Deferred Tax: 82825000.00
UMBFO cash_flow (quarterly, 2025-12-31) — Deferred Tax: 57606000.00
UMBFO cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 141770000.00
UMBFO cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 37397000.00
UMBFO income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 93521000.00
UMBFO income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 25454000.00
UMBFO cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 141770000.00
UMBFO cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 37397000.00
UMBFO income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 93521000.00
UMBFO income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 25454000.00
UMBFO income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 684617000.00
UMBFO income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 209543000.00
UMBFO cash_flow (annual, 2025-12-31) — End Cash Position: 7771973000.00
UMBFO cash_flow (quarterly, 2025-12-31) — End Cash Position: 7771973000.00
UMBFO cash_flow (annual, 2025-12-31) — Financing Cash Flow: 3916687000.00
UMBFO cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 966961000.00
UMBFO cash_flow (annual, 2025-12-31) — Free Cash Flow: 978109000.00
UMBFO cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 95318000.00
UMBFO cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -24765000.00
UMBFO cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: 11323000.00
UMBFO income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 30967000.00
UMBFO income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 2157000.00
UMBFO balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -261520000.00
UMBFO balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -261520000.00
UMBFO income_statement (annual, 2025-12-31) — General And Administrative Expense: 883883000.00
UMBFO income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 228605000.00
UMBFO balance_sheet (annual, 2025-12-31) — Goodwill: 1839825000.00
UMBFO balance_sheet (quarterly, 2025-12-31) — Goodwill: 1839825000.00
UMBFO balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 2337086000.00
UMBFO balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 2337086000.00
UMBFO balance_sheet (annual, 2025-12-31) — Gross PPE: 834928000.00
UMBFO balance_sheet (quarterly, 2025-12-31) — Gross PPE: 834928000.00
UMBFO balance_sheet (annual, 2025-12-31) — Held To Maturity Securities: 5722543000.00
UMBFO balance_sheet (quarterly, 2025-12-31) — Held To Maturity Securities: 5722543000.00
UMBFO cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 63242000.00
UMBFO income_statement (annual, 2025-12-31) — Interest Expense: 1492075000.00
UMBFO income_statement (quarterly, 2025-12-31) — Interest Expense: 364376000.00
UMBFO income_statement (annual, 2025-12-31) — Interest Income: 3354280000.00
UMBFO income_statement (quarterly, 2025-12-31) — Interest Income: 886876000.00
UMBFO cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 1466097000.00
UMBFO balance_sheet (annual, 2025-12-31) — Invested Capital: 7653697000.00
UMBFO balance_sheet (quarterly, 2025-12-31) — Invested Capital: 7653697000.00
UMBFO cash_flow (annual, 2025-12-31) — Investing Cash Flow: -5620098000.00
UMBFO cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -2142475000.00
UMBFO balance_sheet (annual, 2025-12-31) — Investments And Advances: 19992817000.00
UMBFO balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 19992817000.00
UMBFO cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 529207000.00
UMBFO cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 0.00
UMBFO cash_flow (annual, 2025-12-31) — Issuance Of Debt: 0.00
UMBFO cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 0.00
UMBFO balance_sheet (annual, 2025-12-31) — Land And Improvements: 101446000.00
UMBFO balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 101446000.00
UMBFO balance_sheet (annual, 2025-12-31) — Long Term Debt: 254195000.00
UMBFO balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 254195000.00
UMBFO balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 254195000.00
UMBFO balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 254195000.00
UMBFO cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -200000000.00
UMBFO cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: 0.00
UMBFO cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: 169262000.00
UMBFO cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: -874000.00
UMBFO cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 217513000.00
UMBFO cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -79000.00
UMBFO income_statement (annual, 2025-12-31) — Net Income: 702398000.00
UMBFO income_statement (quarterly, 2025-12-31) — Net Income: 215355000.00
UMBFO income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 684617000.00
UMBFO income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 209543000.00
UMBFO income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 702398000.00
UMBFO income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 215355000.00
UMBFO income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 702398000.00
UMBFO income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 215355000.00
UMBFO income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 702398000.00
UMBFO income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 215355000.00
UMBFO cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 702398000.00
UMBFO cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 215355000.00
UMBFO income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 702398000.00
UMBFO income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 215355000.00
UMBFO income_statement (annual, 2025-12-31) — Net Interest Income: 1862205000.00
UMBFO income_statement (quarterly, 2025-12-31) — Net Interest Income: 522500000.00
UMBFO cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -2407341000.00
UMBFO cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: -276514000.00
UMBFO cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -200000000.00
UMBFO cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: 0.00
UMBFO cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -200000000.00
UMBFO cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: 0.00
UMBFO cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -524000.00
UMBFO cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: 0.00
UMBFO cash_flow (annual, 2025-12-31) — Net Other Investing Changes: -33631000.00
UMBFO cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: -35965000.00
UMBFO balance_sheet (annual, 2025-12-31) — Net PPE: 387879000.00
UMBFO balance_sheet (quarterly, 2025-12-31) — Net PPE: 387879000.00
UMBFO cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -48584000.00
UMBFO cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -10759000.00
UMBFO cash_flow (annual, 2025-12-31) — Net Preferred Stock Issuance: 179066000.00
UMBFO cash_flow (quarterly, 2025-12-31) — Net Preferred Stock Issuance: 0.00
UMBFO cash_flow (annual, 2025-12-31) — Net Short Term Debt Issuance: 0.00
UMBFO cash_flow (quarterly, 2025-12-31) — Net Short Term Debt Issuance: 0.00
UMBFO balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 5356482000.00
UMBFO balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 5356482000.00
UMBFO income_statement (annual, 2025-12-31) — Normalized Income: 702398000.00
UMBFO income_statement (quarterly, 2025-12-31) — Normalized Income: 215355000.00
UMBFO income_statement (annual, 2025-12-31) — Occupancy And Equipment: 138637000.00
UMBFO income_statement (quarterly, 2025-12-31) — Occupancy And Equipment: 34911000.00
UMBFO cash_flow (annual, 2025-12-31) — Operating Cash Flow: 1026693000.00
UMBFO cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 106077000.00
UMBFO cash_flow (annual, 2025-12-31) — Operating Gains Losses: -27402000.00
UMBFO cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 10627000.00
UMBFO income_statement (annual, 2025-12-31) — Operating Revenue: 2429906000.00
UMBFO income_statement (quarterly, 2025-12-31) — Operating Revenue: 664949000.00
UMBFO balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 75960675.00
UMBFO balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 75960675.00
UMBFO balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -261520000.00
UMBFO balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -261520000.00
UMBFO balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 497261000.00
UMBFO balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 497261000.00
UMBFO cash_flow (annual, 2025-12-31) — Other Non Cash Items: 4213000.00
UMBFO cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 1980000.00
UMBFO income_statement (annual, 2025-12-31) — Other Non Interest Expense: 146424000.00
UMBFO income_statement (quarterly, 2025-12-31) — Other Non Interest Expense: 41810000.00
UMBFO balance_sheet (annual, 2025-12-31) — Other Properties: 217476000.00
UMBFO balance_sheet (quarterly, 2025-12-31) — Other Properties: 217476000.00
UMBFO balance_sheet (annual, 2025-12-31) — Other Receivables: 586312000.00
UMBFO balance_sheet (quarterly, 2025-12-31) — Other Receivables: 586312000.00
UMBFO balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 8777029000.00
UMBFO balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 8777029000.00
UMBFO balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 435351000.00
UMBFO balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 435351000.00
UMBFO balance_sheet (annual, 2025-12-31) — Preferred Securities Outside Stock Equity: 220034000.00
UMBFO balance_sheet (quarterly, 2025-12-31) — Preferred Securities Outside Stock Equity: 220034000.00
UMBFO balance_sheet (annual, 2025-12-31) — Preferred Stock: 294066000.00
UMBFO balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 294066000.00
UMBFO income_statement (annual, 2025-12-31) — Preferred Stock Dividends: 17781000.00
UMBFO income_statement (quarterly, 2025-12-31) — Preferred Stock Dividends: 5812000.00
UMBFO balance_sheet (annual, 2025-12-31) — Preferred Stock Equity: 294066000.00
UMBFO balance_sheet (quarterly, 2025-12-31) — Preferred Stock Equity: 294066000.00
UMBFO cash_flow (annual, 2025-12-31) — Preferred Stock Issuance: 294066000.00
UMBFO cash_flow (quarterly, 2025-12-31) — Preferred Stock Issuance: 0.00
UMBFO cash_flow (annual, 2025-12-31) — Preferred Stock Payments: -115000000.00
UMBFO cash_flow (quarterly, 2025-12-31) — Preferred Stock Payments: 0.00
UMBFO income_statement (annual, 2025-12-31) — Pretax Income: 874955000.00
UMBFO income_statement (quarterly, 2025-12-31) — Pretax Income: 270309000.00
UMBFO cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 1308000.00
UMBFO cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 366000.00
UMBFO income_statement (annual, 2025-12-31) — Professional Expense And Contract Services Expense: 92304000.00
UMBFO income_statement (quarterly, 2025-12-31) — Professional Expense And Contract Services Expense: 23614000.00
UMBFO cash_flow (annual, 2025-12-31) — Purchase Of Investment: -5432480000.00
UMBFO cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -929648000.00
UMBFO cash_flow (annual, 2025-12-31) — Purchase Of PPE: -48584000.00
UMBFO cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -10759000.00
UMBFO balance_sheet (annual, 2025-12-31) — Receivables: 586312000.00
UMBFO balance_sheet (quarterly, 2025-12-31) — Receivables: 586312000.00
UMBFO income_statement (annual, 2025-12-31) — Reconciled Depreciation: 141770000.00
UMBFO income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 37397000.00
UMBFO cash_flow (annual, 2025-12-31) — Repayment Of Debt: -200000000.00
UMBFO cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: 0.00
UMBFO cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -132628000.00
UMBFO cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -79000.00
UMBFO balance_sheet (annual, 2025-12-31) — Retained Earnings: 3736413000.00
UMBFO balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 3736413000.00
UMBFO income_statement (annual, 2025-12-31) — Salaries And Wages: 883883000.00
UMBFO income_statement (quarterly, 2025-12-31) — Salaries And Wages: 228605000.00
UMBFO cash_flow (annual, 2025-12-31) — Sale Of Investment: 3025139000.00
UMBFO cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 653134000.00
UMBFO income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 45682000.00
UMBFO income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 15246000.00
UMBFO income_statement (annual, 2025-12-31) — Selling General And Administration: 929565000.00
UMBFO income_statement (quarterly, 2025-12-31) — Selling General And Administration: 243851000.00
UMBFO balance_sheet (annual, 2025-12-31) — Share Issued: 78665809.00
UMBFO balance_sheet (quarterly, 2025-12-31) — Share Issued: 78665809.00
UMBFO cash_flow (annual, 2025-12-31) — Short Term Debt Issuance: 0.00
UMBFO cash_flow (quarterly, 2025-12-31) — Short Term Debt Issuance: 0.00
UMBFO cash_flow (annual, 2025-12-31) — Short Term Debt Payments: 0.00
UMBFO cash_flow (quarterly, 2025-12-31) — Short Term Debt Payments: 0.00
UMBFO cash_flow (annual, 2025-12-31) — Stock Based Compensation: 37745000.00
UMBFO cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 9313000.00
UMBFO balance_sheet (annual, 2025-12-31) — Stockholders Equity: 7693568000.00
UMBFO balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 7693568000.00
UMBFO balance_sheet (annual, 2025-12-31) — Tangible Book Value: 5062416000.00
UMBFO balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 5062416000.00
UMBFO income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
UMBFO income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
UMBFO income_statement (annual, 2025-12-31) — Tax Provision: 172557000.00
UMBFO income_statement (quarterly, 2025-12-31) — Tax Provision: 54954000.00
UMBFO income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.20
UMBFO income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.20
UMBFO balance_sheet (annual, 2025-12-31) — Total Assets: 73094090000.00
UMBFO balance_sheet (quarterly, 2025-12-31) — Total Assets: 73094090000.00
UMBFO balance_sheet (annual, 2025-12-31) — Total Capitalization: 7947763000.00
UMBFO balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 7947763000.00
UMBFO balance_sheet (annual, 2025-12-31) — Total Debt: 254195000.00
UMBFO balance_sheet (quarterly, 2025-12-31) — Total Debt: 254195000.00
UMBFO balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 7693568000.00
UMBFO balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 7693568000.00
UMBFO balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 65400522000.00
UMBFO balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 65400522000.00
UMBFO balance_sheet (annual, 2025-12-31) — Trading Securities: 22331000.00
UMBFO balance_sheet (quarterly, 2025-12-31) — Trading Securities: 22331000.00
UMBFO balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 2705134.00
UMBFO balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 2705134.00
UMBFO balance_sheet (annual, 2025-12-31) — Treasury Stock: 165104000.00
UMBFO balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 165104000.00
UMBFO income_statement (quarterly, 2026-03-31) — +Total Revenue: 685259000.00
UMBFO balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 4006726000.00
UMBFO income_statement (quarterly, 2026-03-31) — Amortization: 23460000.00
UMBFO income_statement (quarterly, 2026-03-31) — Amortization Of Intangibles Income Statement: 23460000.00
UMBFO balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 13431588000.00
UMBFO cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 7771973000.00
UMBFO cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -4517000.00
UMBFO balance_sheet (quarterly, 2026-03-31) — Capital Stock: 372732000.00
UMBFO balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 6391119000.00
UMBFO balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Federal Funds Sold: 7915788000.00
UMBFO cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -39611000.00
UMBFO balance_sheet (quarterly, 2026-03-31) — Cash Financial: 735829000.00
UMBFO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -522207000.00
UMBFO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -1349699000.00
UMBFO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 361273000.00
UMBFO cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: -123188000.00
UMBFO cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: 173884000.00
UMBFO cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -123188000.00
UMBFO cash_flow (quarterly, 2026-03-31) — Change In Receivables: 6954000.00
UMBFO cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 57650000.00
UMBFO cash_flow (quarterly, 2026-03-31) — Changes In Cash: -1510633000.00
UMBFO balance_sheet (quarterly, 2026-03-31) — Common Stock: 78666000.00
UMBFO cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: -39611000.00
UMBFO balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 7532931000.00
UMBFO cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 0.00
UMBFO cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -32814000.00
UMBFO balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 309932000.00
UMBFO cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: 21123000.00
UMBFO cash_flow (quarterly, 2026-03-31) — Deferred Tax: 21123000.00
UMBFO cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 35094000.00
UMBFO income_statement (quarterly, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 23460000.00
UMBFO cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 35094000.00
UMBFO income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 23460000.00
UMBFO income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 255625000.00
UMBFO cash_flow (quarterly, 2026-03-31) — End Cash Position: 6261340000.00
UMBFO cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -522207000.00
UMBFO cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 356756000.00
UMBFO cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: -4920000.00
UMBFO income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: 3046000.00
UMBFO balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -331350000.00
UMBFO income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 219681000.00
UMBFO balance_sheet (quarterly, 2026-03-31) — Goodwill: 1837594000.00
UMBFO balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 2301003000.00
UMBFO balance_sheet (quarterly, 2026-03-31) — Held To Maturity Securities: 5699881000.00
UMBFO income_statement (quarterly, 2026-03-31) — Interest Expense: 332701000.00
UMBFO income_statement (quarterly, 2026-03-31) — Interest Income: 867067000.00
UMBFO cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 345994000.00
UMBFO balance_sheet (quarterly, 2026-03-31) — Invested Capital: 7788919000.00
UMBFO cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -1349699000.00
UMBFO balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 19932902000.00
UMBFO cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 0.00
UMBFO balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 255988000.00
UMBFO balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 255988000.00
UMBFO cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: 0.00
UMBFO cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: 0.00
UMBFO cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -32814000.00
UMBFO income_statement (quarterly, 2026-03-31) — Net Income: 261438000.00
UMBFO income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 255625000.00
UMBFO income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 261438000.00
UMBFO income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 261438000.00
UMBFO income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 261438000.00
UMBFO cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 261438000.00
UMBFO income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 261438000.00
UMBFO income_statement (quarterly, 2026-03-31) — Net Interest Income: 534366000.00
UMBFO cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -13885000.00
UMBFO cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: 0.00
UMBFO cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: 0.00
UMBFO balance_sheet (quarterly, 2026-03-31) — Net PPE: 391020000.00
UMBFO cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -4517000.00
UMBFO balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 5525994000.00
UMBFO income_statement (quarterly, 2026-03-31) — Normalized Income: 261438000.00
UMBFO income_statement (quarterly, 2026-03-31) — Occupancy And Equipment: 32395000.00
UMBFO cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 361273000.00
UMBFO cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -4707000.00
UMBFO income_statement (quarterly, 2026-03-31) — Operating Revenue: 685259000.00
UMBFO balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 75977250.00
UMBFO balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -331350000.00
UMBFO balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 463409000.00
UMBFO cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: -1629000.00
UMBFO income_statement (quarterly, 2026-03-31) — Other Non Interest Expense: 28568000.00
UMBFO balance_sheet (quarterly, 2026-03-31) — Other Receivables: 749820000.00
UMBFO balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 777228000.00
UMBFO balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 309932000.00
UMBFO balance_sheet (quarterly, 2026-03-31) — Preferred Securities Outside Stock Equity: 221176000.00
UMBFO balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 294066000.00
UMBFO income_statement (quarterly, 2026-03-31) — Preferred Stock Dividends: 5813000.00
UMBFO balance_sheet (quarterly, 2026-03-31) — Preferred Stock Equity: 294066000.00
UMBFO income_statement (quarterly, 2026-03-31) — Pretax Income: 331276000.00
UMBFO cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 452000.00
UMBFO income_statement (quarterly, 2026-03-31) — Professional Expense And Contract Services Expense: 9087000.00
UMBFO cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -737693000.00
UMBFO cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -4517000.00
UMBFO balance_sheet (quarterly, 2026-03-31) — Receivables: 749820000.00
UMBFO income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 35094000.00
UMBFO cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: 0.00
UMBFO cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -32814000.00
UMBFO balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 3958611000.00
UMBFO income_statement (quarterly, 2026-03-31) — Salaries And Wages: 219681000.00
UMBFO cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 723808000.00
UMBFO income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 13792000.00
UMBFO income_statement (quarterly, 2026-03-31) — Selling General And Administration: 233473000.00
UMBFO balance_sheet (quarterly, 2026-03-31) — Share Issued: 78665809.00
UMBFO cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 13423000.00
UMBFO balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 7826997000.00
UMBFO balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 5231928000.00
UMBFO income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
UMBFO income_statement (quarterly, 2026-03-31) — Tax Provision: 69838000.00
UMBFO income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.21
UMBFO balance_sheet (quarterly, 2026-03-31) — Total Assets: 72674161000.00
UMBFO balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 8082985000.00
UMBFO balance_sheet (quarterly, 2026-03-31) — Total Debt: 255988000.00
UMBFO balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 7826997000.00
UMBFO balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 64847164000.00
UMBFO balance_sheet (quarterly, 2026-03-31) — Trading Securities: 24205000.00
UMBFO balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 2688559.00
UMBFO balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 179722000.00
UMC cash_flow (annual, 2021-12-31) — Asset Impairment Charge: 0.00
UMC income_statement (annual, 2021-12-31) — Average Dilution Earnings: 0.00
UMC cash_flow (annual, 2021-12-31) — Common Stock Dividend Paid: -19871129000.00
UMC cash_flow (annual, 2021-12-31) — Common Stock Issuance: 0.00
UMC cash_flow (annual, 2021-12-31) — Common Stock Payments: 0.00
UMC balance_sheet (annual, 2021-12-31) — Current Debt: 1924124000.00
UMC income_statement (annual, 2021-12-31) — Impairment Of Capital Assets: 0.00
UMC balance_sheet (annual, 2021-12-31) — Income Tax Payable: 7049691000.00
UMC cash_flow (annual, 2021-12-31) — Issuance Of Capital Stock: 0.00
UMC cash_flow (annual, 2021-12-31) — Net Common Stock Issuance: 0.00
UMC cash_flow (annual, 2021-12-31) — Repurchase Of Capital Stock: 0.00
UMC balance_sheet (annual, 2021-12-31) — Treasury Shares Number: 105000000.00
UMC income_statement (annual, 2022-12-31) — +Operating Expense: 22145245000.00
UMC income_statement (annual, 2022-12-31) — +Total Revenue: 278705264000.00
UMC balance_sheet (annual, 2022-12-31) — Accounts Payable: 8982418000.00
UMC balance_sheet (annual, 2022-12-31) — Accounts Receivable: 36444510000.00
UMC balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -889789211000.00
UMC balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 12921310000.00
UMC balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -209101000.00
UMC cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 2841334000.00
UMC cash_flow (annual, 2022-12-31) — Amortization Of Intangibles: 2841334000.00
UMC balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 11984034000.00
UMC income_statement (annual, 2022-12-31) — Average Dilution Earnings: 0.00
UMC income_statement (annual, 2022-12-31) — Basic Average Shares: 2461103800.00
UMC income_statement (annual, 2022-12-31) — Basic EPS: 35.45
UMC cash_flow (annual, 2022-12-31) — Beginning Cash Position: 132622131000.00
UMC balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 40165436000.00
UMC cash_flow (annual, 2022-12-31) — Capital Expenditure: -82883783000.00
UMC balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 5737095000.00
UMC balance_sheet (annual, 2022-12-31) — Capital Stock: 125047490000.00
UMC balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 173818777000.00
UMC balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 178599569000.00
UMC cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -37445300000.00
UMC balance_sheet (annual, 2022-12-31) — Cash Equivalents: 131390311000.00
UMC balance_sheet (annual, 2022-12-31) — Cash Financial: 42428466000.00
UMC cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -57254750000.00
UMC cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -54427266000.00
UMC cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 145860529000.00
UMC cash_flow (annual, 2022-12-31) — Change In Account Payable: 490949000.00
UMC cash_flow (annual, 2022-12-31) — Change In Inventory: -7637528000.00
UMC cash_flow (annual, 2022-12-31) — Change In Other Current Assets: -4041038000.00
UMC cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: 783240000.00
UMC cash_flow (annual, 2022-12-31) — Change In Other Working Capital: -1045911000.00
UMC cash_flow (annual, 2022-12-31) — Change In Payable: 9721433000.00
UMC cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 9721433000.00
UMC cash_flow (annual, 2022-12-31) — Change In Receivables: -2078060000.00
UMC cash_flow (annual, 2022-12-31) — Change In Working Capital: -4297864000.00
UMC cash_flow (annual, 2022-12-31) — Changes In Cash: 34178513000.00
UMC balance_sheet (annual, 2022-12-31) — Common Stock: 125047490000.00
UMC cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -37445300000.00
UMC balance_sheet (annual, 2022-12-31) — Common Stock Equity: 322467269000.00
UMC cash_flow (annual, 2022-12-31) — Common Stock Issuance: 0.00
UMC cash_flow (annual, 2022-12-31) — Common Stock Payments: 0.00
UMC balance_sheet (annual, 2022-12-31) — Construction In Progress: 74803502000.00
UMC income_statement (annual, 2022-12-31) — Cost Of Revenue: 152940887000.00
UMC balance_sheet (annual, 2022-12-31) — Current Assets: 252371038000.00
UMC balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 537314000.00
UMC balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 537314000.00
UMC balance_sheet (annual, 2022-12-31) — Current Deferred Assets: 877000000.00
UMC balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 3546815000.00
UMC balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 3546815000.00
UMC balance_sheet (annual, 2022-12-31) — Current Liabilities: 112608723000.00
UMC cash_flow (annual, 2022-12-31) — Depreciation: 41328374000.00
UMC cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 44169708000.00
UMC cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 44169708000.00
UMC income_statement (annual, 2022-12-31) — Diluted Average Shares: 2539971800.00
UMC income_statement (annual, 2022-12-31) — Diluted EPS: 34.35
UMC income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 89478805000.00
UMC cash_flow (annual, 2022-12-31) — Dividend Received Cfo: 4132529000.00
UMC balance_sheet (annual, 2022-12-31) — Duefrom Related Parties Current: 530577000.00
UMC income_statement (annual, 2022-12-31) — EBIT: 111410971000.00
UMC income_statement (annual, 2022-12-31) — EBITDA: 155580679000.00
UMC income_statement (annual, 2022-12-31) — Earnings From Equity Interest: 1626103000.00
UMC cash_flow (annual, 2022-12-31) — Earnings Losses From Equity Investments: -1626103000.00
UMC cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: 7018133000.00
UMC balance_sheet (annual, 2022-12-31) — Employee Benefits: 2869402000.00
UMC cash_flow (annual, 2022-12-31) — End Cash Position: 173818777000.00
UMC balance_sheet (annual, 2022-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 17784651000.00
UMC cash_flow (annual, 2022-12-31) — Financing Cash Flow: -57254750000.00
UMC balance_sheet (annual, 2022-12-31) — Finished Goods: 2675390000.00
UMC balance_sheet (annual, 2022-12-31) — Foreign Currency Translation Adjustments: -6369416000.00
UMC cash_flow (annual, 2022-12-31) — Free Cash Flow: 62976746000.00
UMC cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: -915081000.00
UMC cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of Business: -50553000.00
UMC cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: -482983000.00
UMC income_statement (annual, 2022-12-31) — Gain On Sale Of Ppe: 482983000.00
UMC income_statement (annual, 2022-12-31) — Gain On Sale Of Security: 1325435000.00
UMC balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: 21173337000.00
UMC income_statement (annual, 2022-12-31) — General And Administrative Expense: 9672613000.00
UMC balance_sheet (annual, 2022-12-31) — Goodwill: 7614000.00
UMC balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 4275200000.00
UMC balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 36653611000.00
UMC balance_sheet (annual, 2022-12-31) — Gross PPE: 1087822827000.00
UMC income_statement (annual, 2022-12-31) — Gross Profit: 125764377000.00
UMC income_statement (annual, 2022-12-31) — Interest Expense: 1785311000.00
UMC income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 1785311000.00
UMC income_statement (annual, 2022-12-31) — Interest Income: 2022314000.00
UMC income_statement (annual, 2022-12-31) — Interest Income Non Operating: 2022314000.00
UMC cash_flow (annual, 2022-12-31) — Interest Paid Cfo: -1422337000.00
UMC cash_flow (annual, 2022-12-31) — Interest Received Cfo: 1852783000.00
UMC balance_sheet (annual, 2022-12-31) — Inventory: 31069960000.00
UMC balance_sheet (annual, 2022-12-31) — Invested Capital: 362344654000.00
UMC cash_flow (annual, 2022-12-31) — Investing Cash Flow: -54427266000.00
UMC balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 29768685000.00
UMC balance_sheet (annual, 2022-12-31) — Investments And Advances: 56273598000.00
UMC cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 0.00
UMC cash_flow (annual, 2022-12-31) — Issuance Of Debt: 2548351000.00
UMC balance_sheet (annual, 2022-12-31) — Land And Improvements: 7730169000.00
UMC balance_sheet (annual, 2022-12-31) — Leases: 63075000.00
UMC balance_sheet (annual, 2022-12-31) — Line Of Credit: 0.00
UMC balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 5199781000.00
UMC balance_sheet (annual, 2022-12-31) — Long Term Debt: 39877385000.00
UMC balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 45077166000.00
UMC cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 2319371000.00
UMC cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -35153534000.00
UMC balance_sheet (annual, 2022-12-31) — Long Term Equity Investment: 26504913000.00
UMC balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 963302380000.00
UMC balance_sheet (annual, 2022-12-31) — Minimum Pension Liabilities: -1831030000.00
UMC balance_sheet (annual, 2022-12-31) — Minority Interest: 343679000.00
UMC income_statement (annual, 2022-12-31) — Minority Interests: -819960000.00
UMC cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: 0.00
UMC cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 0.00
UMC cash_flow (annual, 2022-12-31) — Net Foreign Currency Exchange Gain Loss: 2436159000.00
UMC income_statement (annual, 2022-12-31) — Net Income: 89478805000.00
UMC income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 89478805000.00
UMC income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 90298765000.00
UMC income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 89478805000.00
UMC income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 89478805000.00
UMC cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 109625660000.00
UMC income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 90298765000.00
UMC cash_flow (annual, 2022-12-31) — Net Intangibles Purchase And Sale: -2756155000.00
UMC income_statement (annual, 2022-12-31) — Net Interest Income: 155985000.00
UMC cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: 28228671000.00
UMC cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -34799847000.00
UMC cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -32834163000.00
UMC income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: 155985000.00
UMC cash_flow (annual, 2022-12-31) — Net Other Financing Charges: 14990397000.00
UMC cash_flow (annual, 2022-12-31) — Net Other Investing Changes: -441436000.00
UMC balance_sheet (annual, 2022-12-31) — Net PPE: 198033616000.00
UMC cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -79458346000.00
UMC cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: -1965684000.00
UMC balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 318192069000.00
UMC balance_sheet (annual, 2022-12-31) — Non Current Deferred Assets: 5226236000.00
UMC balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 4000624000.00
UMC balance_sheet (annual, 2022-12-31) — Non Current Deferred Revenue: 438188000.00
UMC balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 5226236000.00
UMC balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 3562436000.00
UMC balance_sheet (annual, 2022-12-31) — Non Current Prepaid Assets: 2749691000.00
UMC income_statement (annual, 2022-12-31) — Normalized EBITDA: 153774984000.00
UMC income_statement (annual, 2022-12-31) — Normalized Income: 87991452235.45
UMC cash_flow (annual, 2022-12-31) — Operating Cash Flow: 145860529000.00
UMC cash_flow (annual, 2022-12-31) — Operating Gains Losses: -434710000.00
UMC income_statement (annual, 2022-12-31) — Operating Income: 103619132000.00
UMC income_statement (annual, 2022-12-31) — Operating Revenue: 265600173000.00
UMC balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 12504748984.00
UMC balance_sheet (annual, 2022-12-31) — Other Current Assets: 2627849000.00
UMC balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 30179814000.00
UMC balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: 26481200000.00
UMC balance_sheet (annual, 2022-12-31) — Other Equity Interest: 2221709000.00
UMC income_statement (annual, 2022-12-31) — Other Gand A: 9672613000.00
UMC income_statement (annual, 2022-12-31) — Other Income Expense: 5850543000.00
UMC balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 4267586000.00
UMC cash_flow (annual, 2022-12-31) — Other Non Cash Items: -4401911000.00
UMC balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 5716204000.00
UMC balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 37278720000.00
UMC income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 2418745000.00